Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CCKBR | P32239 | 1/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.38 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RBP4 | P02753 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8597022 | 1.00 | ATM (0.42) | ATMMEN1KMT2APOLBCCKBR | |
| Water SCHEMBL8600954 | 0.99 | ATM (0.42) | ATMMEN1KMT2APOLBCCKBR | |
| SCHEMBL9327248 | 0.90 | MAPT (0.46) | ATMMEN1KMT2APOLBNAALAD2 | |
| SCHEMBL11431737 | 0.90 | MAPT (0.46) | ATMMEN1KMT2APOLBNAALAD2 | |
| SCHEMBL9567734 | 0.90 | MAPT (0.46) | ATMMEN1KMT2APOLBNAALAD2 | |
| SCHEMBL10543158 | 0.90 | POLB (0.40) | MEN1KMT2APOLBCCKBRMAPT | |
| SCHEMBL9814590 | 0.90 | MEN1 (0.38) | MEN1KMT2APOLBCCKBRMAPT | |
| SCHEMBL8600205 | 0.90 | POLB (0.40) | MEN1KMT2APOLBCCKBRMAPT | |
| SCHEMBL10372875 | 0.90 | GPR88 (0.39) | MEN1KMT2APOLBCCKBRMAPT | |
| SCHEMBL11282995 | 0.90 | ATM (0.42) | ATMMEN1KMT2ACCKBRNAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117579426-A | Heterogeneous communication networking device based on FC-AE-ASM and configuration method thereof | 中国船舶集团有限公司第七一九研究所 | 2024-02-20 | — | — | CN | claimed |
| CN-116646071-A | ERCP intelligent auxiliary diagnosis model training method and system thereof | 中南大学湘雅三医院 | 2023-08-25 | — | — | CN | claimed |
| EP-3601738-B1 | OPPOSED PISTON ENGINE WITH OFFSET INLET AND EXHAUST CRANKSHAFTS | VOLVO TRUCK CORP (SE) | 2023-02-01 | — | — | EP | claimed |
| US-11514498-B2 | System and method for intelligent guided shopping | BEIJING JINGDONG SHANGKE INFORMATION TECHNOLOGY CO., LTD. (CN) | 2022-11-29 | — | — | US | claimed |
| US-12619851-B2 | Labeled molded body | YUPO CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| CN-223944774-U | Drainage nose bile duct tip concatenation combination joint | 鞍钢集团公司总医院 | 2026-02-27 | — | — | CN | disclosed |
| US-20260037458-A1 | INSTRUCTIONS USED IN COMMUNICATIONS BETWEEN COMPUTING DEVICE(S) AND A SHARED ADAPTER | IBM (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250190740-A1 | LABELED MOLDED BODY | YUPO CORPORATION (JP) | 2025-06-12 | — | — | US | disclosed |
| WO-2025052688-A1 | LABELED MOLDED OBJECT | 株式会社ユポ・コーポレーション | 2025-03-13 | — | — | WO | disclosed |
| US-20250063976-A1 | CROP YIELD MODELING BASED ON YIELD POTENTIAL | BASF CORP (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2025023316-A1 | AGENT FOR IMPROVING IMPLANTATION RATE AND METHOD FOR PRODUCING AGENT FOR IMPROVING IMPLANTATION RATE | 国立大学法人東北大学 | 2025-01-30 | — | — | WO | disclosed |
| CN-119330894-A | Method for synthesizing HO-EPCP by catalyzing DMAP | 山东鑫泉医药有限公司 | 2025-01-21 | — | — | CN | disclosed |
| US-4529698-A | Culturing Chromobacterium | E. R. SQUIBB & SONS, INC. (US) | 1985-07-16 | — | — | US | disclosed |
| US-4478749-A | AMINO ACID DERTIVATIVES ANTIBIOTICS | E. R. SQUIBB & SONS, INC. (US) | 1984-10-23 | — | — | US | disclosed |
| EP-0085291-A1 | 2-Oxo-1-(aminocarbonylaminosulfonylaminocarbonyl)azetidines | E.R. Squibb & Sons, Inc. (US) | 1983-08-10 | — | — | EP | disclosed |
| EP-0068466-A1 | 4-Aryl or heteroaryl thio-2-oxo-1-azetidinesulfonic acid salts and process for their preparation | E.R. Squibb & Sons, Inc. (US) | 1983-01-05 | — | — | EP | disclosed |
| EP-0062876-A1 | 2-Oxo-1-(((substituted sulfonyl)amino)carbonyl)azetidines | E.R. Squibb & Sons, Inc. (US) | 1982-10-20 | — | — | EP | disclosed |
| EP-0061763-A1 | 4-Substituted mercapto-2-oxo-1-azetidinesulfonic acid salts and process for their preparation | E.R. SQUIBB & SONS, INC. (US) | 1982-10-06 | — | — | EP | disclosed |
| EP-0061765-A1 | Beta-Lactams | E.R. SQUIBB & SONS, INC. (US) | 1982-10-06 | — | — | EP | disclosed |
| US-4291164-A | CATALYTIC REDUCTION OF AZIDE DERIVATIVE TO AMINE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1981-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12619851-B2 | Labeled molded body | FLNB, FLNA, RIF1 | ATM 3067/4885MEN1 1464/4885KMT2A 2154/4885 |
| US-20260037458-A1 | INSTRUCTIONS USED IN COMMUNICATIONS BETWEEN COMPUTING DEVICE(S) AND A SHARED ADAPTER | SET, SAMM50, MTREX | ATM 65/4885MEN1 617/4885KMT2A 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.